TPO and spindle cell hemangioma: This study aims to assess the roles of anti-TPO and hsCRP as inflammatory markers in SCH and to examine their correlations with clinical symptoms, lipid profiles, and cardiovascular risk, to stratify patients based on their autoimmune and inflammatory profiles.